Skip to main content

Advertisement

SpringerLink
Log in

Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Increased numbers of mast cells is a typical feature of a variety of human cancers. The major mediators in the secretory granules of the MCTC type of mast cells, serine proteinases tryptase and chymase, may be involved in squamous cell carcinoma (SCC) lesions by inducing matrix remodeling and epithelial cell detachment. The objective of this study was to analyze immunohistochemically whether MCTC mast cells as well as protease inhibitors, squamous cell carcinoma antigens (SCCAs), are present in the uterine cervical SCC. In addition, the effect of tryptase and chymase on uterine cervical SCC cell lines was studied in vitro. Here we report that tryptase- and chymase-positive mast cells are present in significant numbers in the peritumoral stroma of SCC lesions. Also, weak SCCA-2 immunoreactivity is observed in the SCC lesions, but only SCCA-1 in uterine cervical specimens with nonspecific inflammation. In cell cultures, especially chymase, but not tryptase, was shown to induce effective detachment of viable, growing and non-apoptotic SiHa SCC cells from substratum. Chymase also detached viable ME-180 SCC cells from substratum as well as degraded fibronectin. In contrast, normal keratinocytes underwent apoptotic cell death after similar prolonged chymase treatment. No inhibition of chymase was detected by SiHa cell sonicates nor did these cells express marked SCCA immunopositivity. MCTC mast cells containing tryptase and chymase are present in the peritumoral stroma of uterine cervical SCC and the malignant cells are only weakly immunoreactive for the chymase inhibitor SCCA-2. It is chymase that appears to be capable of inducing effective detachment of viable and growing SCC cells and therefore, it may release SCC cells from a tumor leading to spreading of malignant cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Abbreviations

SCC:

Squamous cell carcinoma

MMP:

Metalloproteinase

ECM:

Extracellular matrix

MCTC :

Tryptase and chymase positive mast cell

MCT :

Tryptase positive mast cell

MCC :

Chymase positive mast cell

CIN:

Cervical intraepithelial neoplasia

IC:

Invasive carcinoma

SCCA:

Squamous cell carcinoma antigen

References

  1. Briggaman RA, Schechter NM, Fraki J, Lazarus GS (1984) Degradation of the epidermal–dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 160:1027–1042

    Article  PubMed  CAS  Google Scholar 

  2. Cabanillas-Saez A, Schalper JA, Nicovani SM, Rudolph MI (2002) Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int J Gynecol Cancer 12:92–98

    Article  PubMed  CAS  Google Scholar 

  3. Campbell B, De’Ambrosis B (1990) Squamous cell carcinoma antigen in patients with cutaneous disorders. J Am Acad Dermatol 22:639–642

    Article  PubMed  CAS  Google Scholar 

  4. Chin D, Boyle GM, Kane AJ et al (2005) Invasion and metastasis markers in cancers. Br J Plast Surg 58:466–474

    Article  PubMed  Google Scholar 

  5. Ch’ng S, Wallis RA, Yuan L, Davis PF, Tan ST (2006) Mast cells and cutaneous malignancies. Mod Pathol 19:149–159

    Article  PubMed  Google Scholar 

  6. Coussens LM, Raymond WM, Bergers G et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382–1397

    Google Scholar 

  7. Diaconu NC, Kaminska R, Naukkarinen A, Harvima R, Harvima I (2007) The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma. J Eur Acad Dermatol Venereol 21:908–915

    Article  PubMed  Google Scholar 

  8. Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Nilsson G, Harvima IT (2007) Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma. Cancer Immunol Immunother 56:1407–1415

    Article  PubMed  CAS  Google Scholar 

  9. Diaconu NC, Rummukainen J, Mättö M et al (2008) Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis. BMC Cancer 8:46. doi:10.1186/1471-2407-8-46

    Article  PubMed  Google Scholar 

  10. Duk JM, van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW (1989) Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 64:1652–1656

    Article  PubMed  CAS  Google Scholar 

  11. Duncan L, Richards L, Mihm M Jr (1998) Increased mast cell density in invasive melanoma. J Cutan Pathol 25:11–15

    Article  PubMed  CAS  Google Scholar 

  12. Ebihara N, Funaki T, Murakami A, Takai S, Miyazaki M (2005) Mast cell chymase decreases the barrier function and inhibits the migration of corneal epithelial cells. Curr Eye Res 30:1061–1069

    Article  PubMed  CAS  Google Scholar 

  13. Ebihara N, Takai S, Miyazaki M, Murakami A (2005) Mast cell chymase induces conjunctival epithelial cell apoptosis by a mechanism involving degradation of fibronectin. Curr Eye Res 30:429–435

    Article  PubMed  CAS  Google Scholar 

  14. Goldstein SM, Leong J, Schwartz LB, Cooke D (1992) Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J Immunol 148:2475–2482

    PubMed  CAS  Google Scholar 

  15. Gruber BL, Marchese MJ, Suzuki K et al (1989) Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 84:1657–1660

    Article  PubMed  CAS  Google Scholar 

  16. Harvima IT, Heikura H, Hyttinen M, Naukkarinen A (2006) Hyaluronic acid inhibits the adherence and growth of monolayer keratinocytes but does not affect the growth of keratinocyte epithelium. Arch Dermatol Res 298:207–219

    Article  PubMed  CAS  Google Scholar 

  17. Harvima IT, Lappalainen K, Hirvonen M-R et al (2004) Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-α on cultured human keratinocytes. J Cell Biochem 92:372–386

    Article  PubMed  CAS  Google Scholar 

  18. Harvima IT, Naukkarinen A, Paukkonen K et al (1993) Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 285:184–192

    Article  PubMed  CAS  Google Scholar 

  19. Harvima IT, Nilsson G, Suttle MM, Naukkarinen A (2008) Is there a role for mast cells in psoriasis? Arch Dermatol Res 300:461–478

    Article  PubMed  CAS  Google Scholar 

  20. Harvima IT, Schechter NM, Harvima RJ, Fraki JE (1988) Human skin tryptase: purification, partial characterization and comparison with human lung tryptase. Biochim Biophys Acta 957:71–80

    Article  PubMed  CAS  Google Scholar 

  21. Hsu KF, Huang SC, Shiau AL et al (2007) Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer 17:174–181

    Article  PubMed  Google Scholar 

  22. Huttunen M, Harvima IT (2005) Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br J Dermatol 152:1149–1160

    Article  PubMed  CAS  Google Scholar 

  23. Iamaroon A, Pongsiriwet S, Jittidecharaks S, Pattanaporn K, Prapayasatok S, Wanachantararak S (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 32:195–199

    Article  PubMed  Google Scholar 

  24. Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB (1989) Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti/tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509–1515

    Article  PubMed  CAS  Google Scholar 

  25. Iwasaki M, Nishikawa A, Akutagawa N et al (2004) E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. Exp Cell Res 299:525–532

    Article  PubMed  CAS  Google Scholar 

  26. Iwasaki M, Nishikawa A, Fujimoto T et al (2002) Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines. Gynecol Oncol 85:103–107

    Article  PubMed  CAS  Google Scholar 

  27. Kaminska R, Helisalmi P, Harvima RJ, Naukkarinen A, Horsmanheimo M, Harvima IT (1999) Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase. J Invest Dermatol 113:567–573

    Article  PubMed  CAS  Google Scholar 

  28. Kankkunen JP, Harvima IT, Naukkarinen A (1997) Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 72:385–388

    Article  PubMed  CAS  Google Scholar 

  29. Kato H (1996) Expression and function of squamous cell carcinoma antigen. Anticancer Res 16:2149–2153

    PubMed  CAS  Google Scholar 

  30. Kivinen PK, Kaminska R, Naukkarinen A, Harvima RJ, Horsmanheimo M, Harvima IT (2001) Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells. Exp Dermatol 10:246–255

    Article  PubMed  CAS  Google Scholar 

  31. Kivinen PK, Nilsson G, Naukkarinen A, Harvima IT (2003) Mast cell survival and apoptosis in organ-cultured human skin. Exp Dermatol 12:53–60

    Article  PubMed  CAS  Google Scholar 

  32. Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M (1995) Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 38:290–293

    Article  PubMed  CAS  Google Scholar 

  33. Lazaar AL, Plotnick MI, Kucich U et al (2002) Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol 169:1014–1020

    PubMed  CAS  Google Scholar 

  34. Lees M, Taylor DJ, Woolley DE (1994) Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not gelatinases A and B. Eur J Biochem 223:171–177

    Article  PubMed  CAS  Google Scholar 

  35. Leskinen MJ, Lindstedt KA, Wang Y, Kovanen PT (2003) Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. Arterioscler Thromb Vasc Biol 23:238–243

    Article  PubMed  CAS  Google Scholar 

  36. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336

    Article  PubMed  CAS  Google Scholar 

  37. Liotta LA, Tryggvason K, Garbisa S, Hart I, Folts CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68

    Article  PubMed  CAS  Google Scholar 

  38. Lohi J, Harvima I, Keski-Oja J (1992) Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem 50:337–340

    Article  PubMed  CAS  Google Scholar 

  39. Murakami A, Nakagawa T, Kaneko M et al (2006) Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression. Int J Oncol 29:1231–1235

    PubMed  CAS  Google Scholar 

  40. Murakami A, Suminami Y, Sakaguchi Y et al (2000) Specific detection and quantitation of SCC antigen 1 and SCC antigen 2 mRNAs by fluorescence-based asymmetric semi-nested reverse transcription PCR. Tumour Biol 21:224–234

    Article  PubMed  CAS  Google Scholar 

  41. Nawata S, Murakami A, Torii M et al (2006) Different expression patterns of intact forms of squamous cell carcinoma antigens between normal and malignant cervical squamous epithelial tissues: nondenaturing polyacrylamide gel electrophoretic analysis. Oncol Rep 16:399–404

    PubMed  CAS  Google Scholar 

  42. Nienartowicz A, Sobaniec-Lotowska ME, Jarocka-Cyrta E, Lemancewicz D (2006) Mast cells in neoangiogenesis. Med Sci Monit 12:53–56

    Google Scholar 

  43. Nishikawa A, Iwasaki M, Akutagawa N et al (2000) Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential. Gynecol Oncol 79:256–263

    Article  PubMed  CAS  Google Scholar 

  44. Nyberg P, Ylipalosaari M, Sorsa T, Salo T (2006) Trypsins and their role in carcinoma growth. Exp Cell Res 312:1219–1228

    Article  PubMed  CAS  Google Scholar 

  45. Okumura K, Takai S, Muramatsu M et al (2004) Human chymase degrades human fibronectin. Clin Chim Acta 347:223–225

    Article  PubMed  CAS  Google Scholar 

  46. Otto FJ (1994) High-resolution analysis of nuclear DNA employing the fluorochrome DAPI. Methods Cell Biol 41:211–217

    Article  PubMed  CAS  Google Scholar 

  47. Pereira PJ, Bergner A, Macedo-Ribeiro S et al (1998) Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392:306–311

    Article  PubMed  CAS  Google Scholar 

  48. Ribatti D, Ennas M, Vacca A et al (2003) Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33:420–425

    Article  PubMed  CAS  Google Scholar 

  49. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT (1994) Activation of human interstitial procollagenase through direct cleavage of the leu83–thr84 bond by mast cell chymase. J Biol Chem 269:18134–18140

    PubMed  CAS  Google Scholar 

  50. Schick C, Kamachi Y, Bartuski AJ et al (1997) Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 272:1849–1855

    Article  PubMed  CAS  Google Scholar 

  51. Stack MS, Johnson DA (1994) Human mast cell tryptase activates single-chain urinary type plasminogen activator (pro-urokinase). J Biol Chem 269:9416–9419

    PubMed  CAS  Google Scholar 

  52. Stenman J, Hedström J, Grénman R, Leivo I, Finne P, Palotie A, Orpana A (2001) Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck. Int J Cancer 95:39–43

    Article  PubMed  CAS  Google Scholar 

  53. Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541–573

    Article  PubMed  CAS  Google Scholar 

  54. Takanami I, Takeuchi K, Naruke M (2000) Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88:2686–2692

    Article  PubMed  CAS  Google Scholar 

  55. Tiltman AJ (2005) The pathology of cervical tumours. Best Pract Res Clin Obstet Gynaecol 19:485–500

    Article  PubMed  CAS  Google Scholar 

  56. Weidner N, Austen KF (1993) Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract 189:156–162

    PubMed  CAS  Google Scholar 

  57. Wolf K, Friedl P (2006) Molecular mechanisms of cancer cell invasion and plasticity. Br J Dermatol 154:11–15

    Article  PubMed  CAS  Google Scholar 

  58. Yoshii M, Jikuhara A, Mori S et al (2005) Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. J Pharmacol Sci 98:450–458

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Ms Anne Koivisto and Ms Katja Dufva for expert technical assistance and the Marie Curie Mobility Actions for Early Stage Researcher by the sixth framework of the EU commission (project no. 504926), the Finnish Cultural Foundation, Cancer Center of Eastern Finland and Kuopio University Hospital for financing this study.

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, P.O. Box 1777, 70211, Kuopio, Finland

    Nicolae-Costin Diaconu, Rauno J. Harvima & Ilkka T. Harvima

  2. Department of Pathology, Kuopio University Hospital, Kuopio, Finland

    Jaana Rummukainen & Anita Naukkarinen

  3. Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland

    Mikko Mättö & Jukka Pelkonen

Authors
  1. Nicolae-Costin Diaconu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaana Rummukainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anita Naukkarinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mikko Mättö
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rauno J. Harvima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jukka Pelkonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ilkka T. Harvima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolae-Costin Diaconu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diaconu, NC., Rummukainen, J., Naukkarinen, A. et al. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro. Arch Dermatol Res 303, 499–512 (2011). https://doi.org/10.1007/s00403-011-1121-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-011-1121-4

Keywords

Search

Navigation